Portfolio company
Matchpoint Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
6 investors
Sectors
About
This biotechnology company develops oral covalent small molecule medicines to treat patients with autoimmune and inflammatory diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Odyssey Therapeutics
This biopharmaceutical company develops oral small molecule and protein medicines for patients with autoimmune and inflammatory diseases.
Enlaza Therapeutics
This biotechnology company develops covalent protein medicines that form irreversible bonds with disease targets to treat patients with cancer and autoimmune conditions.
Promakhos Therapeutics
This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.
Forward Therapeutics
The company develops oral small-molecule medicines for patients with chronic immunological and inflammatory disorders.
Beeline Medicines
This clinical-stage biotechnology company develops precision therapies for patients living with autoimmune and inflammatory diseases.
Evommune
This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.
Sitryx
This biopharmaceutical company develops oral small molecule medicines that target immune cell metabolism to treat patients with chronic autoimmune and inflammatory diseases.
HotSpot Therapeutics
The company develops allosteric small molecule medicines for patients with cancer and autoimmune diseases by targeting natural regulatory pockets on proteins.